US Bancorp’s OrthoPediatrics KIDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.01K | Buy |
471
+69
| +17% | +$1.2K | ﹤0.01% | 3487 |
|
|
2026
Q1 | $6.38K | Sell |
402
-311
| -44% | -$5.43K | ﹤0.01% | 3503 |
|
|
2025
Q4 | $12.7K | Sell |
713
-637
| -47% | -$11.2K | ﹤0.01% | 3251 |
|
|
2025
Q3 | $25K | Sell |
1,350
-229
| -15% | -$4.72K | ﹤0.01% | 2980 |
|
|
2025
Q2 | $33.9K | Sell |
1,579
-743
| -32% | -$16.1K | ﹤0.01% | 2961 |
|
|
2025
Q1 | $57.2K | Buy |
2,322
+13
| +0.6% | +$321 | ﹤0.01% | 2686 |
|
|
2024
Q4 | $53.5K | Sell |
2,309
-412
| -15% | -$10.3K | ﹤0.01% | 2708 |
|
|
2024
Q3 | $73.8K | Sell |
2,721
-379
| -12% | -$11.5K | ﹤0.01% | 2545 |
|
|
2024
Q2 | $89.2K | Sell |
3,100
-145
| -4% | -$4.45K | ﹤0.01% | 2393 |
|
|
2024
Q1 | $94.6K | Sell |
3,245
-1,189
| -27% | -$33.2K | ﹤0.01% | 2395 |
|
|
2023
Q4 | $144K | Sell |
4,434
-1,694
| -28% | -$49.1K | ﹤0.01% | 2177 |
|
|
2023
Q3 | $196K | Sell |
6,128
-49
| -0.8% | -$1.89K | ﹤0.01% | 1838 |
|
|
2023
Q2 | $271K | Sell |
6,177
-335
| -5% | -$15.4K | ﹤0.01% | 1721 |
|
|
2023
Q1 | $288K | Buy |
6,512
+132
| +2% | +$5.83K | ﹤0.01% | 1694 |
|
|
2022
Q4 | $253K | Sell |
6,380
-533
| -8% | -$22.2K | ﹤0.01% | 1732 |
|
|
2022
Q3 | $320K | Sell |
6,913
-289
| -4% | -$14.2K | ﹤0.01% | 1602 |
|
|
2022
Q2 | $311K | Sell |
7,202
-386
| -5% | -$17.7K | ﹤0.01% | 1678 |
|
|
2022
Q1 | $411K | Sell |
7,588
-1,212
| -14% | -$61.9K | ﹤0.01% | 1620 |
|
|
2021
Q4 | $527K | Sell |
8,800
-594
| -6% | -$37K | ﹤0.01% | 1500 |
|
|
2021
Q3 | $615K | Sell |
9,394
-213
| -2% | -$13.8K | ﹤0.01% | 1422 |
|
|
2021
Q2 | $607K | Sell |
9,607
-437
| -4% | -$25.1K | ﹤0.01% | 1447 |
|
|
2021
Q1 | $489K | Sell |
10,044
-39
| -0.4% | -$1.87K | ﹤0.01% | 1512 |
|
|
2020
Q4 | $416K | Sell |
10,083
-1,044
| -9% | -$47.9K | ﹤0.01% | 1539 |
|
|
2020
Q3 | $510K | Buy |
11,127
+936
| +9% | +$43.4K | ﹤0.01% | 1322 |
|
|
2020
Q2 | $447K | Sell |
10,191
-886
| -8% | -$39.8K | ﹤0.01% | 1356 |
|
|
2020
Q1 | $438K | Buy |
11,077
+2,062
| +23% | +$92.4K | ﹤0.01% | 1271 |
|
|
2019
Q4 | $423K | Buy |
9,015
+2,771
| +44% | +$107K | ﹤0.01% | 1456 |
|
|
2019
Q3 | $221K | Buy |
6,244
+1,937
| +45% | +$67.1K | ﹤0.01% | 1755 |
|
|
2019
Q2 | $168K | Buy |
4,307
+375
| +10% | +$15.1K | ﹤0.01% | 1917 |
|
|
2019
Q1 | $173K | Buy |
3,932
+20
| +0.5% | +$761 | ﹤0.01% | 1890 |
|
|
2018
Q4 | $137K | Buy |
+3,912
| New | +$124K | ﹤0.01% | 1952 |
|
Other funds holding KIDS
B
GIM
SCM
WA
US Bancorp's KIDS Position: Q2 2026 in Review
US Bancorp increased its OrthoPediatrics (KIDS) stake by 17% in Q2 2026, buying an estimated $1.2K and bringing the position to 471 shares worth $9.01K. The position accounts for ﹤0.01% of the portfolio, ranked #3487.
US Bancorp first reported a position in KIDS in Q4 2018 and has held it in 31 quarters since. The position peaked at $615K in Q3 2021. 119 funds tracked by Wall St. Rank hold KIDS as of Q2 2026.
- US Bancorp held 471 shares of OrthoPediatrics worth $9.01K as of Q2 2026.
- US Bancorp bought 69 OrthoPediatrics shares in Q2 2026, an estimated $1.2K.
- OrthoPediatrics made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3487 holding.
- US Bancorp first reported a position in OrthoPediatrics in Q4 2018 and has held it in 31 quarters since.
- US Bancorp's OrthoPediatrics position peaked at $615K in Q3 2021.
- 119 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.